Annual Report

ARROWHEAD PHARMACEUTICALS, INC. Filed 2022-11-28 Acc 0001628280-22-030869

Documents 1

2023-11-29 10-K Annual Report
2022-12-05 S-3ASR Registration Statement
2022-11-28 10-K Annual Report
2022-11-28 8-K Results of operations
2022-11-22 4 Chief Medical Officer sold 19,500 shares at an average $29.99 ($584,738)
2021-11-22 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading arwr-20220930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…